Katja Walpurgis

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Liquid Chromatography

Loop Mediated Isothermal Amplification

Top Venues

Drug testing and analysis

Proteomics. Clinical applications

This page only lists publications with an associated author ORCID identifier.

Publications

Luisa Euler, Kim Deinert, Felicitas Wagener, Katja Walpurgis, Mario Thevis
Identification of human metabolites of fast skeletal troponin activators Tirasemtiv and Reldesemtiv for doping control purposes. Drug testing and analysis (2024)
Katja Walpurgis, Andreas Thomas, Mitsuhiko Sato, Masato Okano, Hans Geyer, Mario Thevis
Detection of the GH analog somatrogon in sports drug testing: Immunological approaches and LC-HRMS/MS. Drug testing and analysis (2024)
Katja Walpurgis, Aileen Gäde, Andreas Thomas, Soizic Gochard, Philippe Delahaut, Mario Thevis
Detection of extracellular hemoglobin from Arenicola marina in doping control serum samples by means of liquid chromatography and high-resolution tandem mass spectrometry. Drug testing and analysis (2023)
Nana Naumann, Katja Walpurgis, Ana Rubio, Andreas Thomas, Alina Paßreiter, Mario Thevis
Detection of doping control sample substitutions via single nucleotide polymorphism-based ID typing. Drug testing and analysis (2023)
Katja Walpurgis, Johannes Agricola, Andreas Thomas, Mario Thevis
Myostatin inhibitory peptides in sports drug testing. Drug testing and analysis (2023)
Andreas Thomas, Sophia Krombholz, Johanna Breuer, Katja Walpurgis, Mario Thevis
Insulin-mimetic peptides in sports drug testing. Drug testing and analysis (2023)
Tim Sobolevsky, Katja Walpurgis, Christian Görgens, Matthew N Fedoruk, Laura Lewis, Brian Ahrens, Mario Thevis
Detection of capromorelin in urine following oral and dermal routes of administration. Drug testing and analysis (2023)
Katja Walpurgis, Andreas Thomas, Mario Thevis
Detection of the myostatin-neutralizing antibody Domagrozumab in serum by means of Western blotting and LC-HRMS. Drug testing and analysis 11 (11-12) (2020)
Katja Walpurgis, Tim Weigand, Andre Knoop, Andreas Thomas, Christian Reichel, Frank Dellanna, Mario Thevis
Detection of follistatin-based inhibitors of the TGF-β signaling pathways in serum/plasma by means of LC-HRMS/MS and Western blotting. Drug testing and analysis 12 (11-12) (2020)
Katja Walpurgis, Ana Rubio, Felicitas Wagener, Oliver Krug, Andre Knoop, Christian Görgens, Sven Guddat, Mario Thevis
Elimination profiles of microdosed ostarine mimicking contaminated products ingestion. Drug testing and analysis 12 (11-12) (2020)
Ann-Marie Garzinsky, Katja Walpurgis, Oliver Krug, Mario Thevis
Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane? Drug testing and analysis 11 (11-12) (2019)
Katja Walpurgis, Anja B Scheiff, Meike Welz, Jutta Müller-Reul, Nick Webborn, Christian Görgens, Sven Guddat, Gregor Fußhöller, Josef Dib, Mario Thevis
Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples. Drug testing and analysis 11 (11-12) (2019)
Katja Walpurgis, Andreas Thomas, Frank Dellanna, Wilhelm Schänzer, Mario Thevis
Detection of the Human Anti-ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC-HRMS. Proteomics. Clinical applications 12 (3) (2018)
Christian Reichel, Günter Gmeiner, Katja Walpurgis, Mario Thevis
Updated protocols for the detection of Sotatercept and Luspatercept in human serum. Drug testing and analysis 10 (11-12) (2018)
Katja Walpurgis, Andreas Thomas, Tobias Lange, Christian Reichel, Hans Geyer, Mario Thevis
Combined detection of the ActRII-Fc fusion proteins Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC-MS/MS. Drug testing and analysis 10 (11-12) (2018)